Document is current
Any future updates will be listed below
-
Authors
Webert, Lauren K. https://orcid.org/0009-0001-3075-479X
Schantell, Mikki https://orcid.org/0000-0002-2972-1368
Horne, Lucy K. https://orcid.org/0000-0002-7266-7061
John, Jason A.
Glesinger, Ryan https://orcid.org/0009-0000-6505-5967
O’Neill, Jennifer
Kubat, Maureen
Coutant, Anna T.
Ende, Grace C.
Bares, Sara H.
May-Weeks, Pamela E.
Wilson, Tony W. https://orcid.org/0000-0002-5053-8306
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (F31-DA056296)
National Institute on Drug Abuse (R01-DA047828)
National Institute of General Medical Sciences (P20-GM144641)
National Institute of Mental Health (R01-MH116782)
- License Information
-
More Information
Article History
Received: 24 September 2024
Accepted: 19 May 2025
First Online: 6 June 2025
Declarations
:
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The Institutional Review Board of the University of Nebraska Medical Center (UNMC) reviewed and approved this protocol. All participants gave written informed consent following a detailed description of the study.
: Sara Bares reports competing interests with Gilead Sciences, ViiV Healthcare, and Janssen. All other authors declare no conflicts of interest.
